BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32164439)

  • 1. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
    Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
    Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry.
    Tisi S; Dickson JL; Horst C; Quaife SL; Hall H; Verghese P; Gyertson K; Bowyer V; Levermore C; Mullin AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; ; Hurst JR; Janes SM
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35896207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.
    Melzer AC; Feemster LC; Crothers K; Carson SS; Gillespie SE; Henderson AG; Krishnan JA; Lindenauer PK; McBurnie MA; Mularski RA; Naureckas ET; Pickard AS; Au DH;
    Ann Am Thorac Soc; 2016 Sep; 13(9):1490-6. PubMed ID: 27268422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
    Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN; Yu WC; Wong CK; Lam MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
    Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
    Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
    Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
    BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used.
    Jögi J; Markstad H; Tufvesson E; Bjermer L; Bajc M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():25-30. PubMed ID: 25565797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening.
    Mets OM; Schmidt M; Buckens CF; Gondrie MJ; Isgum I; Oudkerk M; Vliegenthart R; de Koning HJ; van der Aalst CM; Prokop M; Lammers JW; Zanen P; Mohamed Hoesein FA; Mali WP; van Ginneken B; van Rikxoort EM; de Jong PA
    Respir Res; 2013 May; 14(1):59. PubMed ID: 23711184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity.
    Bhatt SP; Bodduluri S; Raghav V; Bhakta NR; Wilson CG; Kim YI; Eberlein M; Sciurba FC; Han MK; Dransfield MT; Nakhmani A
    Ann Am Thorac Soc; 2019 Aug; 16(8):982-989. PubMed ID: 30865842
    [No Abstract]   [Full Text] [Related]  

  • 13. COPD phenotypes in a lung cancer screening population.
    Balkan A; Bulut Y; Fuhrman CR; Fisher SN; Wilson DO; Weissfeld JL; Sciurba FC
    Clin Respir J; 2016 Jan; 10(1):48-53. PubMed ID: 24989058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Radiologic Disease in Smokers With Normal Spirometry.
    Regan EA; Lynch DA; Curran-Everett D; Curtis JL; Austin JH; Grenier PA; Kauczor HU; Bailey WC; DeMeo DL; Casaburi RH; Friedman P; Van Beek EJ; Hokanson JE; Bowler RP; Beaty TH; Washko GR; Han MK; Kim V; Kim SS; Yagihashi K; Washington L; McEvoy CE; Tanner C; Mannino DM; Make BJ; Silverman EK; Crapo JD;
    JAMA Intern Med; 2015 Sep; 175(9):1539-49. PubMed ID: 26098755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
    Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
    Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a targeted screening program to detect airflow obstruction suggestive of chronic obstructive pulmonary disease within a presurgical screening clinic.
    Robitaille C; Dajczman E; Hirsch AM; Small D; Ernst P; Porubska D; Palayew M
    Can Respir J; 2015; 22(4):209-14. PubMed ID: 25961279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of undiagnosed chronic obstructive pulmonary disease in a primary care population with respiratory tract infections - a case finding study.
    Sandelowsky H; Ställberg B; Nager A; Hasselström J
    BMC Fam Pract; 2011 Nov; 12():122. PubMed ID: 22047519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.
    Al Ghobain M; Al-Hajjaj MS; Wali SO
    Ann Saudi Med; 2011; 31(2):129-33. PubMed ID: 21403413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.